• Reid Hoffman secures $24.6M to launch Manas AI, an AI-driven cancer research venture. • Co-founded with Siddhartha Mukherjee, author of “The Emperor of All Maladies.” • Manas AI aims to accelerate cancer diagnosis and treatment through advanced machine learning. • The funding underscores growing investor interest in AI-powered oncology solutions. • Hoffman’s move highlights the intersection of tech entrepreneurship and medical innovation.
Article Summaries:
- Reid Hoffman, co‑founder of LinkedIn, has secured $24.6 million in seed funding for his new AI‑driven cancer‑research venture, Manas AI. The startup, co‑founded with Siddhartha Mukherjee-author of the Pulitzer‑winning book The Emperor of All Maladies-aims to leverage artificial intelligence to accelerate the discovery of cancer treatments. The capital will support early‑stage research, data‑collection infrastructure, and the development of machine‑learning models to identify novel therapeutic targets. Manas AI positions itself at the intersection of clinical oncology and advanced AI, drawing on Mukherjee’s medical expertise and Hoffman’s tech‑investment experience.
Sources: